Merck | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Abbott USD 25.02B 408M 2024-09
ALKERMES USD 1.77M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Indivior 65M 2M 2024-09
J&J USD 3.12B 0 2024-12
Medtronic USD 0 128K 2025-01
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Novo Nordisk 446M 0 2024-09
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Pfizer USD 480M 0 2024-12
Prestige Brands USD 559K 2K 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
United Therapeutics USD 800K 100K 2024-12
Zoetis USD 5M 0 2024-12



Merck Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.